featured
Early Discontinuation of Endocrine Therapy for Breast Cancer Risk Reduction Among Patients With DCIS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Toxicity Index, Patient-Reported Outcomes, and Early Discontinuation of Endocrine Therapy for Breast Cancer Risk Reduction in NRG Oncology/NSABP B-35
J. Clin. Oncol 2021 Sep 23;[EPub Ahead of Print], NL Henry, S Kim, RD Hays, MA Diniz, M Luu, RS Cecchini, G Yothers, A Rogatko, PA GanzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.